Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications Nutra Pharma is providing updates on their work in improving capabilities and...
Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys Plantation, FL -- February 12, 2021 --InvestorsHub...
CORAL SPRINGS, Fla., July 24, 2014 (GLOBE NEWSWIRE) -- Nutra Pharma Corp. (OTCPink:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple...
Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company
Nutra Pharma has completed the process of moving all of their inventory of Nyloxin® to their Plantation, Florida facility to begin in-house fulfillment.
Nutra Pharma has completed their first delivery of the Company’s homeopathic pain reliever, Nyloxin®, to their newest distributing partner, New Vitality.
Nutra Pharma is announcing the beginning of the process for the registration of their homeopathic pain drug, Nyloxin™, in South Africa.
Nutra Pharma is providing an update on their efforts to register and market their homeopathic pain drugs with the United States government for sales into the military.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 126345 | 0.0001 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 556265 | 0.0001 | CS |
| 12 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 498556 | 9.588E-5 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 331036 | 9.456E-5 | CS |
| 52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0017 | 1.0E-6 | 460111 | 0.00013425 | CS |
| 156 | -0.0024 | -96 | 0.0025 | 0.0034 | 1.0E-6 | 551888 | 0.00064363 | CS |
| 260 | -0.0006 | -85.7142857143 | 0.0007 | 0.0158 | 1.0E-6 | 10821568 | 0.00318311 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
